Standout Papers

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer 2018 2026 2020 2023 534
  1. Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer (2018)
    Shang‐Gin Wu, Jin‐Yuan Shih Molecular Cancer

Immediate Impact

4 from Science/Nature 55 standout
Sub-graph 1 of 21

Citing Papers

New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Colorimetric sensing for translational applications: from colorants to mechanisms
2024 Standout
1 intermediate paper

Works of Shang‐Gin Wu being referenced

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
2018 Standout

Author Peers

Author Last Decade Papers Cites
Shang‐Gin Wu 1856 1435 668 935 63 2.5k
Mei Hou 1799 1600 530 738 38 2.4k
Viola W. Zhu 2096 1634 632 983 82 2.6k
Haichuan Hu 2252 1565 733 1015 45 2.9k
Roberta Minari 1655 1417 570 1121 65 2.4k
Kenji Tomizawa 1460 1255 381 851 72 2.3k
Teresa Morán 1812 1535 613 1016 129 2.6k
Eva Ciruelos 1338 1427 912 888 76 2.4k
Zofia Piotrowska 2010 1669 526 919 120 2.5k
Kadoaki Ohashi 1793 1630 530 866 133 2.5k
Rui Wang 1697 1172 628 789 65 2.3k

All Works

Loading papers...

Rankless by CCL
2026